TCL Archive In Brief: VP-16 NDA Approved By FDA Only For Refractory Testicular Cancer; Removed From Group C List December 2, 1983
TCL Archive In Brief: NCI’s Reorganization Plan Picks Up Speed In New Bureaucracy, Could Be Approved Soon February 29, 1980